Accretion Pharmaceuticals IPO Subscription.

SME

Accretion Pharmaceuticals: Category QIB offered 1,41,600 shares, applied 17,19,600 shares, with a subscription of 12.14x, and total amount raised is 17.37 Cr. Category HNI offered 12,22,800 shares, applied 53,84,400 shares, with a subscription of 4.40x, and total amount raised is 54.38 Cr. Category Retail offered 12,22,800 shares, applied 1,28,85,600 shares, with a subscription of 10.54x, and total amount raised is 130.14 Cr. Category Total offered 25,87,200 shares, applied 1,99,89,600 shares, with a subscription of 7.73x, and total amount raised is 201.89 Cr.

Accretion Pharmaceuticals: For QIB, - shares were reserved, max winners were -, 4 were applied, application-wise subscription was -, and people-based subscription was -. For HNI, 1,019 shares were reserved, max winners were -, 887 were applied, application-wise subscription was 0.87x, and people-based subscription was -. For Retail, 1,019 shares were reserved, max winners were -, 10,738 were applied, application-wise subscription was 10.54x, and people-based subscription was -. Total applications received were 11,629.

Category	Offered	Applied	Times	Total Amount (Rs Cr.)
QIB	1,41,600	17,19,600	12.14x	17.37
HNI	12,22,800	53,84,400	4.40x	54.38
Retail	12,22,800	1,28,85,600	10.54x	130.14
Total	25,87,200	1,99,89,600	7.73x	201.89

Last Updated : 16 May, 2025 05:58:00 PM

Category	Reserved	Applied	Times
QIB	-	4	-
HNI	1,019	887	0.87x
Retail	1,019	10,738	10.54x

Total Applications: 11629

IPO Investor Categories

Qualified Institutional Buyers (QIB)
Institutions like banks, mutual funds, insurance companies, and other SEBI-registered entities fall under the QIB category. They typically invest large sums on behalf of clients or schemes.
Non-Institutional Investors (NII)
This group includes high-net-worth individuals (HNIs), NRIs, trusts, and companies that apply for shares worth more than ₹2 lakhs. Unlike QIBs, SEBI registration is not required.
NII is further split into:
1. sNII (Applications below ₹10 Lakhs)
  Investors bidding between ₹2 lakhs and ₹10 lakhs fall in the Small NII (sHNI) bracket. One-third of the NII portion is set aside for them.
2. bNII (Applications above ₹10 Lakhs)
  Investors applying for more than ₹10 lakhs are classified as Big NIIs (bHNI). Two-thirds of the NII shares are allocated to this sub-category.
Retail Individual Investors (RII)
Individuals or NRIs applying for shares up to ₹2 lakhs are considered retail investors and are part of the RII quota.
Employee (EMP)
This section is reserved for eligible employees of the company participating in the IPO.
Others
Includes eligible shareholders or specific investors with a reserved quota as per the IPO policy.

Read more about Accretion Pharmaceuticals IPO

Disclaimer: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites. The information / data provided herein is for informational purposes only and is provided by a2zipo.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. a2zipo.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites. a2zipo.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. a2zipo.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites. The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.